OncoMed Pharmaceuticals Inc Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions
OncoMed Pharmaceuticals Inc reported Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions of $628.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-07.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions · last filed 2019-03-07
- OncoMed Pharmaceuticals Inc unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2018 was $628.00K, a 73.81% decline from fiscal 2017.
- OncoMed Pharmaceuticals Inc unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2017 was $2.40M, a 43.42% decline from fiscal 2016.
- OncoMed Pharmaceuticals Inc unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2016 was $4.24M, a 9.21% decline from fiscal 2015.
- OncoMed Pharmaceuticals Inc unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2015 was $4.67M, a 203.31% increase from fiscal 2014.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 12 month |
|---|---|
| 2018-12-31 | $628.00K 10-K · filed 2019-03-07 |
| 2017-12-31 | $2.40M 10-K · filed 2019-03-07 |
| 2016-12-31 | $4.24M 10-K · filed 2019-03-07 |
| 2015-12-31 | $4.67M 10-K · filed 2018-03-09 |
| 2014-12-31 | $1.54M 10-K · filed 2017-03-09 |
| 2013-12-31 | $708.00K 10-K · filed 2016-03-10 |
| 2012-12-31 | $338.00K 10-K · filed 2015-03-12 |
| 2011-12-31 | $567.00K 10-K · filed 2014-03-18 |